Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire

Clinical trial NCT05817331 · COMPLETED

Trial details

NCT number: NCT05817331
Sponsor: Otsuka Australia Pharmaceutical Pty Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2022-06-28
Primary completion: 2023-03-10
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.